Srisai Biopharmaceutical Solutions LLC
Frederick, MD
- UEI
- DMAXAMHK9XL3
- CAGE
- 3X9S1
- Primary NAICS
- 493120 Refrigerated Warehousing and Storage
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 320 Montevue Ln, Frederick, MD 21702, USA
- Website
- srisaibiopharma.com
- Founded
- 2002
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $165,082 |
| FY2025 | $173,805 |
| FY2024 | $67,258 |
| FY2023 | $150,707 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $156,754 | |
| 2 | Defense Health Agency | $8,328 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Kamtek Inc. | Frederick, MD | 493120 Refrigerated Warehousing and Storage |
| Clinical Trials Division | Rockville, MD | 493120 Refrigerated Warehousing and Storage |
| EPL Pathology Archives, LLC | — | 493110 General Warehousing and Storage |
| Alkali Scientific, LLC | Fort Lauderdale, FL | 423490 Other Professional Equipment and Supplies Merchant Wholesalers |
| SRS | Stafford, TX | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
About the company
Srisai Biopharmaceutical Solutions LLC, a Frederick, Maryland–based minority-owned and self-certified small disadvantaged business, provides cryogenic biospecimen storage, management, and associated services to federal health research agencies and the military as a prime contractor on 100% of its awards, with no subcontract footprint.
The company's capability portfolio centers on ultra-low temperature freezer storage for biological specimens, inventory control, sample handling, and dry ice shipment services. Srisai operates predominantly under refrigerated warehousing and storage contracts (19 awards) and testing laboratory services (9 awards) across NAICS 493120 (Refrigerated Warehousing and Storage) and related technical categories. Representative work includes a $2.59 million single-award Indefinite Delivery Contract with CDC Pittsburgh running through March 2030 for NHANES biospecimen storage, under which Srisai maintains 17–23 ultra-low temperature freezers and processes approximately 500,000 biological samples annually in 2ml Nunc Cryo vials; a $344,435 delivery order from CDC Pittsburgh for NHANES biospecimen storage (completed March 2026); and a $59,102 purchase order from the Defense Health Agency (awarded August 2024, running through July 2029) for GMP-certified cryogenic storage of DNA vaccines targeting hantaviruses and alphaviruses, including bacterial cell banks and plasmid DNA vaccine vials.
Customer concentration is pronounced. The top customer by both volume and dollars is the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh, which accounts for 18 awards and $6 million in combined potential value (97% coverage of award count, 63% of all potential value). The Department of the Army Medical Command follows distantly with 2 awards valued at $2.7 million, and the Department of the Navy Bureau of Medicine and Surgery holds 10 awards worth $662 thousand. The National Institute of Allergy and Infectious Diseases maintains a recurring stream of small purchase orders ($12,300 annually) for storage and shipping services.
Srisai holds three active parent IDCs: the CDC Pittsburgh NHANES storage vehicle (7 task orders, $449 thousand combined value), a Navy biorepository IDC (5 task orders, $649 thousand), and an Army Medical Research Acquisition Activity contract (2 task orders, $504 thousand). Activity over the past five years averages fewer than three awards annually, with only one award recorded in 2026 year to date. The recompete cliff in the next twenty-four months carries minimal exposure — $160 thousand in potential value across a single award. The vendor's total combined potential value across 37 prime awards stands at $9.5 million, with $5.1 million obligated (53% realization rate).
Quick answers
Is Srisai Biopharmaceutical Solutions LLC registered in SAM.gov?
Yes. Srisai Biopharmaceutical Solutions LLC's SAM.gov registration is active through November 6, 2026.
How much has Srisai Biopharmaceutical Solutions LLC received in federal contracts?
Federal contracts obligated $173,805 to Srisai Biopharmaceutical Solutions LLC in fiscal year 2025 and $556,851 in fiscal years 2023 through 2027.
What is Srisai Biopharmaceutical Solutions LLC's most recent federal award?
Srisai Biopharmaceutical Solutions LLC's most recent federal contract award is Storage of biospecimens and associated services in support of nhanes (75D30126F00268), from CDC Pittsburgh, on March 15, 2026.
On GovTribe
See Srisai Biopharmaceutical Solutions LLC's full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors